People living with rare and devastating diseases are our Guiding Star. We believe it is our responsibility to listen to, understand, and change the lives of patients and those who work tirelessly to help them. Our culture is rooted in integrity, inclusiveness, and our dedication to joining and supporting the communities in which we live and work. We invest in and value people who believe in the importance of our purpose and understand what it takes to deliver on it. Alexion has over 3,000 talented colleagues dedicated to serving people living with rare diseases in more than 50 countries around the world. Our global headquarters are based in Boston, Massachusetts and our EMEA headquarters are in Zürich, Switzerland. We also have a Research Center of Excellence in New Haven, Connecticut, global supply chain and operations headquarters in Ireland, as well as local and regional operations in countries around the world. At Alexion, our passion drives us to continuously innovate and create meaningful value in all we do. In doing so, we change lives for the better – ours, people living with rare diseases, and the communities we serve. Every day.
Alexion Pharmaceuticals Inc.
121 Seaport Blvd, Boston, MA 02210-2050
CategoryBiotech & Pharmaceuticals
Alexion Pharmaceuticals Inc. demonstrates a strong commitment to environmental sustainability by implementing various initiatives to reduce its ecological footprint. The company focuses on minimizing energy consumption, employing energy-efficient technologies, and sourcing renewable energy where possible to mitigate its carbon emissions. Additionally, Alexion prioritizes responsible waste management and aims to minimize waste generation throughout its operations, contributing to a more circular and sustainable approach to resource utilization. Through these efforts, Alexion contributes to preserving natural resources, lowering greenhouse gas emissions, and promoting a greener future for the pharmaceutical industry.In terms of social impact, Alexion Pharmaceuticals Inc. plays a pivotal role in improving patient well-being and healthcare access. The company’s innovative therapies address critical medical needs and improve patients’ quality of life. Furthermore, Alexion engages in meaningful collaborations with patient advocacy organizations, healthcare professionals, and patient communities to raise awareness, enhance medical education, and foster patient empowerment. By prioritizing patient-centric care and fostering partnerships, Alexion contributes to better healthcare outcomes and societal well-being.Alexion Pharmaceuticals Inc. demonstrates strong governance practices that uphold ethical standards and foster transparency. The company’s board and leadership ensure sound decision-making through comprehensive oversight and risk management processes, while adhering to regulatory requirements and promoting ethical conduct across all operations. Alexion maintains open lines of communication with its stakeholders, including shareholders and patients, and emphasizes diversity and inclusivity within its workforce and leadership positions. This commitment to strong governance fosters accountability, instills trust, and reflects the company’s dedication to ethical leadership within the pharmaceutical sector.Aligned with its ESG principles, Alexion Pharmaceuticals Inc. recognizes that responsible business practices have a positive impact on long-term financial performance. By integrating sustainability considerations into its financial strategy, the company creates value for both shareholders and patients. Through effective risk management and a focus on sustainable growth, Alexion ensures its ability to provide ongoing innovative therapies and drive positive health outcomes. This alignment of financial goals with ESG values not only benefits the organization’s bottom line but also supports its broader mission to improve global health and well-being.Ethical considerations are paramount in Alexion Pharmaceuticals Inc.’s operations. The company is committed to ensuring patient safety and product quality, adhering to rigorous scientific standards and regulatory requirements. Alexion’s ethical approach extends beyond product development, encompassing fair business practices, transparent interactions with healthcare professionals, and responsible marketing of its therapies. By prioritizing ethics throughout its activities, Alexion safeguards patient trust, enhances healthcare integrity, and contributes to a more ethically driven pharmaceutical industry.